NS
BEAM icon

NBC Securities’s Beam Therapeutics BEAM Stock Holding History

NBC Securities’s Portfolio BEAM Stock Details BEAM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$18.2K Hold
763
– – ﹤0.01% 1744
2025
Q4 		$21.1K Sell
763
-1,181
-61% -$30.1K ﹤0.01% 1754
2025
Q3 		$47.2K Buy
+1,944
New +$38.7K ﹤0.01% 1350

Other funds holding BEAM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

NBC Securities's BEAM Position: Q1 2026 in Review

NBC Securities held its Beam Therapeutics (BEAM) position steady in Q1 2026 at 763 shares worth $18.2K. The position accounts for ﹤0.01% of the portfolio, ranked #1744.

NBC Securities first reported a position in BEAM in Q3 2025 and has held it in 3 quarters since. The position peaked at $47.2K in Q3 2025. 251 funds tracked by Wall St. Rank hold BEAM as of Q1 2026.

  • NBC Securities held 763 shares of Beam Therapeutics worth $18.2K as of Q1 2026.
  • NBC Securities left its Beam Therapeutics share count unchanged in Q1 2026.
  • Beam Therapeutics made up ﹤0.01% of NBC Securities's portfolio in Q1 2026, its #1744 holding.
  • NBC Securities first reported a position in Beam Therapeutics in Q3 2025 and has held it in 3 quarters since.
  • NBC Securities's Beam Therapeutics position peaked at $47.2K in Q3 2025.
  • 251 funds tracked by Wall St. Rank held Beam Therapeutics as of Q1 2026.

Based on NBC Securities's 13F filing for Q1 2026, filed 14 Apr 2026.